Compare NRC & TEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NRC | TEI |
|---|---|---|
| Founded | 1981 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 278.8M | 313.6M |
| IPO Year | N/A | N/A |
| Metric | NRC | TEI |
|---|---|---|
| Price | $15.85 | $6.55 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 90.7K | ★ 142.4K |
| Earning Date | 01-26-2026 | 01-01-0001 |
| Dividend Yield | 4.03% | ★ 10.51% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.71 | N/A |
| Revenue | ★ $139,102,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $22.35 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.76 | $4.35 |
| 52 Week High | $19.94 | $5.39 |
| Indicator | NRC | TEI |
|---|---|---|
| Relative Strength Index (RSI) | 49.78 | 60.54 |
| Support Level | $15.90 | $6.27 |
| Resistance Level | $16.53 | $6.68 |
| Average True Range (ATR) | 0.73 | 0.09 |
| MACD | -0.24 | 0.02 |
| Stochastic Oscillator | 7.88 | 65.44 |
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.
Templeton Emerging Markets Income Fund is a closed-end fund. It seeks high, current income, with a secondary goal of capital appreciation, by investing, under normal market conditions. The company's investment portfolio includes Foreign Government and Agency Securities; Quasi-Sovereign and Corporate Bonds; Common Stocks and Other Equity Interests, and Short-Term Investments, and Money Market Funds.